DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Tolaney SM, Wardley AM, Zambelli S. et al.
MonarcHER: a randomized phase 2 study of abemaciclib plus trastuzumab with or without abemaciclib versus trastuzumab plus chemotherapy in women with HR+, HER2+ advanced breast cancer.
Ann Oncol 2019;
30 (Suppl. 05) v851-v934
DOI: 10.1093/annonc/mdz394.
We do not assume any responsibility for the contents of the web pages of other providers.